Alamar Biosciences, Inc.

Welcome aboard, University of Oxford! We can’t wait to see the brilliant research!

We're here in Denver, CO, kicking off #ASHG24! Join us tomorrow, for our Industry Education Lunch Session, from 12-1pm, to hear leading expert, Dr. Carlos Cruchaga, from Washington University in St. Louis, discuss how sensitive and multiplex protein detection with #NULISA is enabling comprehensive insights into inflammation and neurodegenerative diseases. Stop by booth 1065 to see how you can power your multiomics study with the groundbreaking #NULISA technology 👉 https://ow.ly/khVK50U0B1E

We're thrilled to support the 2024 Biomarkers of Aging Consortium Conference at Harvard Medical School this week! Join us as we showcase our groundbreaking #NULISA technology that is unlocking the secrets of biological aging with Gold Standard sensitivity. Learn more about our #NULISAseq CNS Disease Panel 120 — measuring 120 protein biomarkers of CNS disease at the lowest limit of detection 👉 https://ow.ly/59eS50TYe2n #AgingScience #BiomarkersOfAging

Just one day left to register for tomorrow's Precision Biomarker Summit in Boston! Join Alamar and key opinion leaders from Johnson & Johnson Innovative Medicine, Harvard Medical School & Boston Children's Hospital, Brigham and Women's Hospital, and Biognosys, for a discussion on the latest advances in protein biomarker research with an introduction to #NULISA: A precision proteomics platform with ultra-high sensitivity and high multiplex from blood. Register now to save your seat👉 https://ow.ly/Ljrm50TVPcW

Join us at #ASHG2024 in Denver, CO, next week to see how you can elevate your genomics research with the groundbreaking #NULISA Proteomics Platform! Explore how to integrate high-sensitivity and multiplexed protein detection into your research with Dr. Carlos Cruchaga from Washington University School of Medicine in St. Louis during our Industry Lunch Symposium on Nov. 6, 12-1pm in room 107. Don’t miss out on the opportunity to network and learn by visiting booth 1065. Learn more 👉 https://ow.ly/l4cI50TUTlq

✈️ We're headed to Boston for our next Precision Biomarker Summit on October 30. Featuring presentations from Dr. Chris Whelan, with Johnson & Johnson Innovative Medicine, Dr. Hanno Steen, with Harvard Medical School & Boston Children's Hospital, Dr. Jessica Lasky-Su, with Brigham and Women's Hospital & Harvard Medical School, and Dr. Nigel Beaton, with Biognosys, join us for a discussion on the latest advances in protein biomarker research with an introduction to #NULISA: A precision proteomics platform with ultra-high sensitivity and high multiplex from blood. Don’t miss this opportunity to connect, collaborate, and explore the future of #proteomics. Register today 👉 https://ow.ly/Uwos50TIvZB

We are excited to announce our participation at the 2nd Fluid & Imaging Biomarkers & Endpoints in Neuroscience Forum in Boston this week. Join us as we lead panel discussions with experts in the field, to explore the future of neuroscience and advance precision medicine in the CNS! 🧠🔬 Stay up to date on all upcoming conferences and events 👉 https://ow.ly/vkAg50TRkAF #Neuroscience #Multiomics #PrecisionMedicine #Biomarkers

Thank you to all who joined our lunch symposium at #HUPO2024 with featured presentations by Dr. Hanno Steen from Harvard University and Boston Children's Hospital along with Dr. Kristina Beeler from Biognosys If you’re interested in learning about #NULISA or would like a demo of the #ARGO HT System, please come by Booth 25. We’d love to show you more. #proteomics #immunoassay #massspec #drugdiscovery

🧠 Alamar Biosciences' NULISAseq CNS Disease Panel 120 is gaining significant interest from Alzheimer's researchers. Measuring 120+ proteins linked to neurological diseases, the new panel offers a more comprehensive view of Alzheimer's beyond traditional amyloid biomarkers. Researchers like Dr. Thomas Karikari from the University of Pittsburgh have used the panel in recent studies, identifying key proteins linked to Alzheimer's progression, and are hopeful about its potential in diagnostics. Read the full GenomeWeb article for more 👉 https://ow.ly/opHS50TPbOE #AlzheimersResearch #Biomarkers #Neuroscience #Proteomics

Welcome to #HUPO2024! Come talk with Mathias Holpert, Xiao-Jun Ma, Yuling Luo, Anna Berdine, Max Mahoney, or Michael Evans at booth 25 to learn more about #NULISA and how to apply ultra-sensitive protein detection from biofluids to your research! Also, don’t miss our lunch symposium, Tuesday, October 22 at 12pm in the plenary hall with Drs Hanno Steen from Harvard University and Kristina Beeler from Biognosys.